| Literature DB >> 36136669 |
Alessio Pierini1, Eleonora Gori1, Fiorenza Tulone1, Elena Benvenuti2, Enrico Bottero2, Pietro Ruggiero2, Veronica Marchetti1.
Abstract
Few studies have investigated total protein (TP) and serum protein electrophoresis (SPE) in cats with chronic enteropathy (CE). Cats diagnosed with CE were evaluated to investigate the relationships between TP, SPE and endoscopy, histopathology, and extraintestinal involvement. Medical records were searched for cats with a history of chronic gastrointestinal signs and a final diagnosis of CE. Information on signalment, TP, SPE, endoscopic score, histopathological diagnosis and score, and concurrent hepatic or pancreatic ultrasonographic alterations was collected. Relationships between protein profiles and other variables were investigated. Ninety-nine cats were included in the study, 63 diagnosed with various degrees of bowel inflammation and 36 with small-cell alimentary lymphoma. The most common TP alteration was hypoproteinemia (24%). No significant differences were observed between protein profiles and endoscopic and histopathological severity scores. Forty-five cats showing concurrent pancreatic and/or hepatic ultrasonographic alterations, had significantly lower albumin, lower α-globulin, and higher γ-globulin levels than cats not showing concurrent alterations. Disease severity scores did not seem to influence the protein profile in cats with CE. Extraintestinal involvement may be suspected in cats with lower albumin and α-globulins and higher γ-globulins.Entities:
Keywords: cats; chronic enteropathy; electrophoresis; endoscopy; gamma-globulins
Year: 2022 PMID: 36136669 PMCID: PMC9500995 DOI: 10.3390/vetsci9090453
Source DB: PubMed Journal: Vet Sci ISSN: 2306-7381
Figure 1The figure shows the distribution of protein fractions in cats (descriptive statistics). Abs: absolute values. Reference ranges: Total protein 5.5–8 g/dL; Abs. Albumin (2.8–4.0 g/dL); Albumin% (41.6–56.5%); Abs. α-globulins (0.8–2.1 g/dL); α-globulins% (13.2–22.4%); Abs. β-globulins (0.3–1.5 g/dL); β-globulins% (13.1–27.7%); Abs. γ-globulins (0.4–2.0 g/dL); γ-globulins% (6.6–11.6%).
Comparisons of SPE between groups based on endoscopy, histopathology and ultrasonographic findings.
| Endoscopy | Histopathology | Ultrasonographic Findings | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Endo1 | Endo2-3 |
| HistoA | HistoB |
| UEI | UI |
| |
| Total protein | 6 (4–8.5) | 6 (3.4–10.1) | 0.378 | 6 (3.4–9.9) | 6.1 (4.2–10.1) | 0.202 | 7.1 (4.7–10.1) | 7.2 (5.1–10) | 0.897 |
| Absolute values (mg/dL) | |||||||||
| Albumin | 3 (2.1–3.6) | 3 (1.9–4.6) | 0.444 | 3 (1.9–3.9) | 3.1 (2.2–4.6) | 0.090 | 3.3 (1.6–4.6) | 3.5 (2.3–4.5) | 0.074 |
| α-globulins | 1.2 (0.5–2) | 1.3 (0.4–2.5) | 0.138 | 1.3 (0.5–2) | 1.3 (0.4–2.5) | 0.579 | 1.1 (0.6–2.5) | 1.6 (0.4–2) |
|
| β-globulins | 0.6 (0.2–2) | 0.6 (0.3–1.7) | 0.420 | 0.6 (0.2–1.7) | 0.7 (0.3–2) | 0.063 | 0.9 (0.3–2) | 0.8 (0.3–1.9) | 0.295 |
| γ-globulins | 1 (0.2–2.2) | 1 (0.3–5.4) | 0.872 | 0.9 (0.2–5.4) | 1 (0.2–2.9) | 0.294 | 1.5 (0.3–5.4) | 1.2 (0.4–2.9) |
|
| Percentage (%) | |||||||||
| Albumin | 50.5 (34.8–69.1) | 50.2 (26.8–63.1) | 0.861 | 50.3 (26.8–69.1) | 50.3 (34.8–61.6) | 0.599 | 45.9 (26.8–61.9) | 49.5 (37.9–62.1) |
|
| α-globulins | 20.6 (9.1–31.2) | 21.8 (6.9–33.8) | 0.260 | 21.5 (9.1–31.2) | 20.6 (6.9–33.8) | 0.496 | 17.5 (7.8–29.3) | 21 (6.9–33.8) |
|
| β-globulins | 10.4 (6–23.7) | 10.1 (4.6–30.6) | 0.154 | 9.4 (4.6–30.6) | 11.5 (5.3–23.7) | 0.182 | 14.2 (5.1–26.1) | 11.4 (4.6–27.4) | 0.100 |
| γ-globulins | 17.4 (5.2–30.1) | 16.4 (4.6–54.9) | 0.869 | 16.1 (5.2–54.9) | 17.4 (4.6–30.1) | 0.414 | 20.4 (6.1–54.9) | 16.8 (5.9-33.8) |
|
Endo1: cats with endoscopic score 1; Endo2-3 included cats with endoscopic score 2 or 3. HistoA included cats with histological classification of mild or moderate inflammation; HistoB included cats with histological classification of severe inflammation or small cell alimentary lymphoma. UEI included cats with concurrent ultrasonographic hepatic or pancreatic changes; UI included cats with no ultrasonographic hepatic or pancreatic changes. Significances are reported in bold.